Heinrich Highlights Serious Consequences of Losing Health Insurance Premium Rebates in New Mexico
September 27, 2025 - 13:39
U.S. Senator Martin Heinrich addressed the potential repercussions that the loss of health insurance premiums rebates under the Affordable Care Act could have on New Mexico. During a recent discussion, Heinrich emphasized that these rebates play a crucial role in making healthcare affordable for many residents in the state.
He pointed out that the elimination of these financial aids could lead to increased healthcare costs for families, making it more challenging for them to access necessary medical services. The senator expressed concern that vulnerable populations, including low-income individuals and families, would be disproportionately affected by such a loss.
Heinrich's remarks come amid ongoing debates about the future of the Affordable Care Act and its provisions. He urged policymakers to consider the implications of any changes to health insurance programs, stressing the importance of maintaining support for New Mexicans who rely on these vital resources for their health and well-being.
MORE NEWS
October 8, 2026 - 18:55
New Jersey Grows Doula Training Network to 29 Approved ProgramsNew Jersey has expanded the number of doula training programs approved under NJ FamilyCare, bringing the total to 29 across the state. The move aims to widen access to doula support for residents...
October 8, 2026 - 04:20
Blue Cross Downcoding Practices Hit Behavioral Health Providers Across Several StatesBehavioral health providers in at least three states are dealing with downcoding actions from Blue Cross Blue Shield plans, according to reporting from BHB+. The issue involves claims being paid at...
October 7, 2026 - 04:49
Brooklyn Hospital Debuts Massive Mural Focused on Healing and ResilienceA new large-scale mural has transformed a busy corridor at a Brooklyn medical facility, turning a clinical passageway into a space that speaks to recovery, strength, and optimism. The artwork,...
October 6, 2026 - 12:29
The Case Against Approving a Flawed Multicancer Screening TestTelling more people they have cancer is not progress; progress is having fewer people die from cancer. That argument sits at the center of a growing debate over whether regulators should clear a...